Navigation Links
China Sky One Medical, Inc. to Present at Rodman & Renshaw Annual Global Investment Conference and Conduct Non-Deal Roadshow in the U.S.
Date:9/1/2009

HARBIN, China, Sept. 1 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced the Company will present at the upcoming Rodman & Renshaw Annual Global Investment Conference to be held on September 9-11 at the New York Palace Hotel in New York City. The Company will also conduct a non-deal roadshow in the U.S. during the week of September 14.

The Rodman & Renshaw Annual Global Investment Conference is a three-day event which features tracks devoted to Healthcare, Metals & Mining, Energy, Clean-tech, Asia, Community & Regional Banks, Growth, & Maritime. So far, more than 500 companies have registered to attend the conference. Schedule of China Sky One Medical's presentation is as follows:

    Date:     Thursday, September 10th, 2009
    Time:     10:25 a.m. Eastern Time
    Venue:    Louis Salon (4th Floor)
              New York Palace Hotel
              455 Madison Avenue, NY 10022

During the conference, the Company will be available for one-on-one meetings. For more information about the conference, please visit http://www.rodm.com/conferences .

To complement its participation at the conference, China Sky One Medical is also scheduled to launch a non-deal roadshow in the U.S. from September 14-18. Mr. Yan-qing Liu, Chairman and CEO of the Company, and Mr. Stanley Hao, the CFO of China Sky One Medical, will meet with securities analysts and investors in Boston, Chicago, Denver, San Francisco and Los Angeles.

"We are excited to participate in the upcoming conference and conduct a non-deal roadshow in the U.S.," commented Mr. Yan-qing Liu, Chairman and CEO of China Sky One Medical. "This is a unique opportunity for us to present China Sky One Medical's story to meet the investment community and provide an update on our business plan and growth strategy. We value effective and direct communication with our shareholders and potential investors."

The non-deal roadshow is being hosted by CCG Investor Relations. A copy of the presentation to be used for the conference and the roadshow will be posted on the Company's website at http://www.cski.com.cn on or before September 10, 2009.

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio- Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the attendance of investment conferences and non-deal road show meetings. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

    For more information, please contact:

    Company Contact:
     China Sky One Medical, Inc.
     Mr. Stanley Hao, CFO
     Tel:   +86-0451-5399-4069
     Email: stanleyhao@cski.com.cn

    Investor Relations Contact:
     CCG Investor Relations
     Mr. Crocker Coulson, President
     Tel:   +1-646-213-1915
     Email: crocker.coulson@ccgir.com
     Web:  http://www.ccgirasia.com

'/>"/>
SOURCE China Sky One Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results
2. China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results
3. China Medicine Enhances Management Team with Appointments of New Chief Financial Officer and Finance Manager
4. China Sky One Medical, Inc. to Hold Annual Meeting of Shareholders on September 24, 2009
5. Linkwell Corporation Announces Launch of the Establishment of 100 Model Hospitals Across China
6. Linkwell Corporation Announces Launch of the Series of Handwashing Contest Across China
7. China Healthcare Corp. Provides Update on JV to Build its First Hospital in China
8. China Kangtai Cactus Biotech to Attend Rodman & Renshaw Conference and Meet with Investors in September
9. China Nepstar Chain Drugstore Announces Special Dividend
10. China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results
11. China Nepstar Chain Drugstore Announces Management Change
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Brenntag Specialties, Inc.(BSI) ... Food & Beverage and Dietary Supplement market segments across ... and USA geographies east of the Rocky Mountains since 2012. Consistent performance ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... BantamPro L top-load case packer for pouches, bags, and flow wrapped products at ... help co-packers and specialty product manufacturers step up to semi-automatic or fully-automatic case ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... community enrichment program serving the greater Venice, FL area, has initiated a fundraiser ... in a car accident just four days after Christmas. To support this beautiful ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... of organizations. DocuSyst provides a cloud hosted environment for FileHold software that ... integration with various 3rd party applications using the FileHold web services API. DocuSyst ...
(Date:2/8/2016)... ... 08, 2016 , ... Joshua Rosenthal, PhD, Chief Scientific Officer ... use newly released government data on populations and physicians to better calculate risk ... the value they create to succeed in new economic models for value based ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... CARLSBAD, Calif. , Feb. 8, 2016  HemaFlo Therapeutics, ... Office (USPTO) has issued US Patent Number 9,119,880 covering the ... Dale Peterson , PhD, HemaFlo,s founder, said, "We ... technology." --> Dale Peterson , PhD, HemaFlo,s ... such a powerful technology." --> Dale ...
(Date:2/8/2016)... 8, 2016  Dynatronics Corporation (NASDAQ: DYNT ... devices and rehabilitation equipment for the physical therapy, ... Broncos, football team for winning the 2016 World ... Chairman and Chief Executive Officer.  "The Broncos have ... forward to enhancing their athletic achievements with our ...
(Date:2/8/2016)... RICHMOND, Calif. , Feb. 8, 2016 /PRNewswire/ ... leader in therapeutic genome editing, announced that the ... the Company,s Investigational New Drug (IND) application for ... a life-long therapy for Mucopolysaccharidosis Type I (MPS ... and enables Sangamo to initiate a Phase 1/2 ...
Breaking Medicine Technology: